Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Accumulated Expenses: 2018-2024

Historic Accumulated Expenses for Verastem (VSTM) over the last 6 years, with Dec 2024 value amounting to $26.0 million.

  • Verastem's Accumulated Expenses rose 101.87% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 101.87%. This contributed to the annual value of $26.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, Verastem's Accumulated Expenses stood at $26.0 million, which was up 73.21% from $15.0 million recorded in FY2022.
  • Verastem's 5-year Accumulated Expenses high stood at $26.0 million for FY2024, and its period low was $14.7 million during FY2020.
  • Moreover, its 2-year median value for Accumulated Expenses was $20.5 million (2022), whereas its average is $20.5 million.
  • Per our database at Business Quant, Verastem's Accumulated Expenses decreased by 24.30% in 2020 and then grew by 6.56% in 2021.
  • Verastem's Accumulated Expenses (Yearly) stood at $14.7 million in 2020, then increased by 6.56% to $15.6 million in 2021, then dropped by 4.08% to $15.0 million in 2022, then reached $26.0 million in 2024.